Detailed answers about THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED, including incorporation, status, business activity, and accounts information.
When was THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED founded?
THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED was officially incorporated on 24 June 2026 and is registered under company number 17299946. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED?
THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED do?
THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED operates in the following sectors: 86101 - Hospital activities, 86210 - General medical practice activities. These SIC codes provide insight into the company's business activities and industry focus.
What is THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED's registered address?
The registered office address of THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED is 1 Garnett Way, Oakridge Park, Milton Keynes, England, MK14 6FX. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED financially stable?
Financial accounts for THE SKIN INVESTMENT CLINIC BIRMINGHAM LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.